Embecta Corp

NASDAQ:EMBCUnited States

Embecta Corp. is a global diabetes care company. It is focused on providing solutions to people living with diabetes. It has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It has clearance from the FDA for its proprietary disposable insulin delivery system, which is indicated for adults who require insulin to manage diabetes, including both type 1 (T1D) and type 2 (T2D).

Contact Information

Headquarters

300 Kimball Drive, Suite 300PARSIPPANY, NJ, United States NJ 07054

Phone

862-401-0000

Fax

302-655-5049

Executives

Non-Executive Independent Chairman of the Board

David Melcher

President, Chief Executive Officer, Director

Devdatt Kurdikar

Chief Financial Officer, Senior Vice President

Jacob Elguicze

Chief Human Resource Officer, Senior Vice President

Jean Casner

Senior Vice President, Chief Technology Officer

Colleen Riley